neoX (星亢原) combines artificial intelligence (AI) with biophysics for drug research and development. neoX focuses on the research and development of macromolecular drugs, especially in the field of immuno-oncology. It has developed a sophisticated platform for early discovery of therapeutics by characterizing protein-protein interactions (PPI). neoX has established cooperation with biomedical companies globally to accelerate drug R&D pipelines.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2018
- Website
- www.neoxbiotech.com
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of neoX (星亢原)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now